Gregory L. Willis

1.7k total citations
68 papers, 1.4k citations indexed

About

Gregory L. Willis is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems and Neurology. According to data from OpenAlex, Gregory L. Willis has authored 68 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 28 papers in Endocrine and Autonomic Systems and 21 papers in Neurology. Recurrent topics in Gregory L. Willis's work include Parkinson's Disease Mechanisms and Treatments (20 papers), Circadian rhythm and melatonin (17 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Gregory L. Willis is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (20 papers), Circadian rhythm and melatonin (17 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Gregory L. Willis collaborates with scholars based in Australia, United States and Poland. Gregory L. Willis's co-authors include Graeme C. Smith, George Singer, Geoffrey A. Donnan, Aleksandar Videnović, Stuart M. Armstrong, J. Hansky, R.D. Myers, Michael L. McCaleb, Gerard A. Kennedy and Alan D. Robertson and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Scientific Reports.

In The Last Decade

Gregory L. Willis

68 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory L. Willis Australia 22 603 590 502 337 260 68 1.4k
Davor Stanić Australia 22 347 0.6× 895 1.5× 387 0.8× 218 0.6× 369 1.4× 47 1.6k
Joan F. Lorden United States 26 283 0.5× 1.1k 1.9× 467 0.9× 467 1.4× 415 1.6× 68 1.9k
Augusto Fernández‐Guardiola Mexico 19 297 0.5× 717 1.2× 170 0.3× 621 1.8× 217 0.8× 75 1.4k
Francisco E. Olucha‐Bordonau Spain 22 190 0.3× 690 1.2× 178 0.4× 537 1.6× 310 1.2× 56 2.0k
Nigel I. Wood United Kingdom 23 247 0.4× 1.4k 2.4× 461 0.9× 305 0.9× 1.1k 4.1× 39 2.1k
J.P. Herman France 25 170 0.3× 1.4k 2.3× 397 0.8× 387 1.1× 408 1.6× 52 1.9k
Rawien Balesar Netherlands 21 346 0.6× 316 0.5× 135 0.3× 281 0.8× 348 1.3× 38 1.5k
Dawn H. Loh United States 26 1.1k 1.8× 800 1.4× 204 0.4× 491 1.5× 543 2.1× 34 2.0k
Jing‐Ning Zhu China 25 583 1.0× 391 0.7× 118 0.2× 499 1.5× 352 1.4× 71 1.8k
Daniela Noaín Switzerland 17 177 0.3× 419 0.7× 180 0.4× 356 1.1× 274 1.1× 29 984

Countries citing papers authored by Gregory L. Willis

Since Specialization
Citations

This map shows the geographic impact of Gregory L. Willis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory L. Willis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory L. Willis more than expected).

Fields of papers citing papers by Gregory L. Willis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory L. Willis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory L. Willis. The network helps show where Gregory L. Willis may publish in the future.

Co-authorship network of co-authors of Gregory L. Willis

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory L. Willis. A scholar is included among the top collaborators of Gregory L. Willis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory L. Willis. Gregory L. Willis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willis, Gregory L., et al.. (2024). Circadian Intervention Improves Parkinson’s Disease and May Slow Disease Progression: A Ten Year Retrospective Study. Brain Sciences. 14(12). 1218–1218. 1 indexed citations
2.
Willis, Gregory L., et al.. (2017). The effect of directed photic stimulation of the pineal on experimental Parkinson's disease. Physiology & Behavior. 182. 1–9. 2 indexed citations
3.
Willis, Gregory L., et al.. (2017). Neurochemical Systems of the Retina Involved in the Control of Movement. Frontiers in Neurology. 8. 324–324. 7 indexed citations
4.
Willis, Gregory L., et al.. (2017). The effect of intravitreal cholinergic drugs on motor control. Behavioural Brain Research. 339. 232–238. 2 indexed citations
5.
Willis, Gregory L., et al.. (2017). Emerging preclinical interest concerning the role of circadian function in Parkinson’s disease. Brain Research. 1678. 203–213. 5 indexed citations
6.
Willis, Gregory L., et al.. (2015). Breast cancer metastasis to the vulva 20 years remote from initial diagnosis: A case report and literature review. SHILAP Revista de lepidopterología. 13. 33–35. 6 indexed citations
7.
Willis, Gregory L., et al.. (2014). Parkinson's Disease, Lights and Melanocytes: Looking Beyond the Retina. Scientific Reports. 4(1). 3921–3921. 17 indexed citations
8.
Willis, Gregory L., et al.. (2012). Breaking away from dopamine deficiency: an essential new direction for Parkinson’s disease. Reviews in the Neurosciences. 23(4). 403–28. 12 indexed citations
9.
10.
Willis, Gregory L., et al.. (2008). Compromised circadian function in Parkinson's disease: Enucleation augments disease severity in the unilateral model. Behavioural Brain Research. 193(1). 37–47. 20 indexed citations
11.
Willis, Gregory L., et al.. (2007). Primary and Secondary Features of Parkinson's Disease Improve with Strategic Exposure to Bright Light: A Case Series Study. Chronobiology International. 24(3). 521–537. 105 indexed citations
12.
Willis, Gregory L. & Gerard A. Kennedy. (2004). The Implementation of Acute versus Chronic Animal Models for Treatment Discovery in Parkinson's Disease. Reviews in the Neurosciences. 15(1). 75–87. 26 indexed citations
13.
Willis, Gregory L., et al.. (2004). Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23. Pharmacology Biochemistry and Behavior. 80(1). 9–26. 19 indexed citations
14.
Willis, Gregory L., et al.. (1999). A Therapeutic Role For Melatonin Antagonism in Experimental Models of Parkinson’s Disease. Physiology & Behavior. 66(5). 785–795. 73 indexed citations
15.
Willis, Gregory L., Graeme C. Smith, Geoffrey Pavey, & Reuven Sandyk. (1992). Amelioration of Experimental Parkinsonism by Intrahypothalamic Administration of Haloperidol. International Journal of Neuroscience. 65(1-4). 187–197. 4 indexed citations
16.
Willis, Gregory L. & Reuven Sandyk. (1992). Sensitivity of Dopamine Receptors in the Lateral Hypothalamus is Altered in 6-Hydroxydopamine Treated Rats. International Journal of Neuroscience. 65(1-4). 199–207. 4 indexed citations
17.
Sleeman, Mark W., et al.. (1989). Changes in Food Intake and Stomach Contents of Tumor‐Bearing Rats After Treatment With Dopamine Antagonists. Nutrition and Cancer. 12(1). 49–55. 2 indexed citations
18.
Willis, Gregory L., et al.. (1988). i.r. β-endorphin, corticosterone, cholesterol and triglyceride concentrations in rat plasma after stress, cingulotomy or both. Pharmacology Biochemistry and Behavior. 31(1). 75–79. 6 indexed citations
19.
Giacalone, Joseph C., Neil A. Wells, & Gregory L. Willis. (1987). Observations on Syntheosciurus brochus (Sciuridae) in Volcan Poas National Park, Costa Rica. Journal of Mammalogy. 68(1). 145–147. 3 indexed citations
20.
Willis, Gregory L. & Graeme C. Smith. (1982). The behavioural effects of intrahypothalamic multistage versus single injections of 6-hydroxydopamine. Brain Research. 245(2). 345–352. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Davor Stanić Breakdown of academic impact, for papers by Joan F. Lorden Breakdown of academic impact, for papers by Augusto Fernández‐Guardiola Breakdown of academic impact, for papers by Francisco E. Olucha‐Bordonau Breakdown of academic impact, for papers by Nigel I. Wood Breakdown of academic impact, for papers by J.P. Herman Breakdown of academic impact, for papers by Rawien Balesar Breakdown of academic impact, for papers by Dawn H. Loh Breakdown of academic impact, for papers by Jing‐Ning Zhu Breakdown of academic impact, for papers by Daniela Noaín
Rankless by CCL
2026